Join
Live feed
·
INSIDERFilingvia Quantisnow
Aprea Therapeutics Inc. logo

Director Duey Marc sold $29,583 worth of shares (6,462 units at $4.58), decreasing direct ownership by 3% to 233,651 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
APRE· Aprea Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APRE (Aprea Therapeutics Inc.) and more on Quantisnow.